Answer
Yes, secondary causes of dyslipidaemia, such as hypothyroidism, should be excluded or corrected before starting ciprofibrate or any other lipid-lowering drug treatment.
Sources for this answer
- Ciprofibrate 100mg TabletsZentiva · emc · SmPC §4.4 Special warnings and precautions for use · Version 10Document updated
Sources checked